000
| 01176nam##2200265za#4500 |
---|
001 | 9.645764 |
---|
003 | CaOODSP |
---|
005 | 20200330131020 |
---|
007 | ta |
---|
008 | 150407|1995||||xxc||||| f|0| 0 eng|d |
---|
020 | |a0-662-21711-X |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH42-2/66-1995E |
---|
110 | 1 |aCanada.|bHealth Canada. |bDrugs Directorate. |
---|
245 | 14|aThe role of surrogate markers of HIV infection / |cby C. M. Tsoukas. |
---|
260 | |aOttawa - Ontario : |bHealth Canada. |c1995. |
---|
300 | |a47p. : |breferences, tables ; |c28 cm. |
---|
500 | |aContents: Introduction.--Pathophysiology.--Serologic T cell activation markers.--Serologic B cell activation markers.--Antibodies to HIV.--Other antibodies.--Other serologic markers.--Antigen markers.--Cell surface T cell activation markers.--CD4+ T cells.--Discussion and recommendations.--Glossary.--References. |
---|
563 | |aSoftcover |
---|
590 | |a96-05|b1996-02-02 |
---|
690 | 07|aAIDS (disease)|2gcpds |
---|
720 | 1 |aTsoukas, C. M. |
---|
775 | 08|tLe rôle des marqueurs substituts de l'infection à VIH / |w(CaOODSP)9.679394 |
---|
776 | 0#|tThe role of surrogate markers of HIV infection : |w(CaOODSP)9.695832 |
---|